Gradient Investments
VECT

Gradient Investments’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Gradient Investments’s Portfolio VECT Stock Details VECT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-200
Closed -$1K – 1598
2022
Q2 		$1K Buy
+200
New +$1.08K ﹤0.01% 1194

Other funds holding VECT

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Gradient Investments's VECT Position: Q3 2022 in Review

Gradient Investments sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2022, closing a stake of 200 shares — an estimated $1K sold.

Gradient Investments first reported a position in VECT in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 21 funds tracked by Wall St. Rank hold VECT as of Q3 2022.

  • Gradient Investments reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2022 after selling out during the quarter.
  • Gradient Investments sold 200 VectivBio Holding AG Ordinary Shares shares in Q3 2022, an estimated $1K.
  • Gradient Investments first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2022 and held it in 1 quarter.
  • Gradient Investments's VectivBio Holding AG Ordinary Shares position peaked at $1K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2022.

Based on Gradient Investments's 13F filing for Q3 2022, filed 14 Oct 2022.